BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$367M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$354M |
| 3 |
Apple
AAPL
|
+$151M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$136M |
| 5 |
Alibaba
BABA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$170M |
| 2 |
Amazon
AMZN
|
+$167M |
| 3 |
JPMorgan Chase
JPM
|
+$142M |
| 4 |
Microsoft
MSFT
|
+$142M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.35% |
| 2 | Financials | 7.66% |
| 3 | Healthcare | 6.82% |
| 4 | Communication Services | 6.47% |
| 5 | Consumer Discretionary | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HEES
2376
DELISTED
H&E Equipment Services
HEES
| $33.4K | ﹤0.01% |
1,754
+1,632
| +1,338% | +$30.7K |
|
|
GHDX
2377
DELISTED
Genomic Health, Inc.
GHDX
| $33.3K | ﹤0.01% |
1,285
+1,083
| +536% | +$28.8K |
|
2378
MacroGenics
MGNX
$248M
| $33.3K | ﹤0.01% |
+1,232
| New | +$27.8K |
|
2379
Innoviva
INVA
$1.5B
| $33K | ﹤0.01% |
+3,132
| New | +$37.1K |
|
|
WAIR
2380
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $32.9K | ﹤0.01% |
+2,452
| New | +$34.9K |
|
|
MYCC
2381
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $32.6K | ﹤0.01% |
+2,511
| New | +$32K |
|
2382
National Beverage
FIZZ
$2.93B
| $32.5K | ﹤0.01% |
+1,034
| New | +$26.4K |
|
2383
Theravance Biopharma
TBPH
$879M
| $32.5K | ﹤0.01% |
+1,431
| New | +$30.9K |
|
|
PDLI
2384
DELISTED
PDL BioPharma, Inc.
PDLI
| $32.4K | ﹤0.01% |
10,326
+9,977
| +2,859% | +$33.3K |
|
|
BBT
2385
Beacon Financial Corp
BBT
$2.69B
| $32.2K | ﹤0.01% |
+1,195
| New | +$32.1K |
|
|
UNVR
2386
DELISTED
Univar Solutions Inc.
UNVR
| $31.6K | ﹤0.01% |
+1,673
| New | +$30.4K |
|
|
SAAS
2387
DELISTED
inContact, Inc.
SAAS
| $31.6K | ﹤0.01% |
+2,283
| New | +$26.3K |
|
2388
Seaboard Corp
SEB
$4.05B
| $31.6K | ﹤0.01% |
11
-37
| -77% | -$109K |
|
2389
Sarepta Therapeutics
SRPT
$1.89B
| $31.6K | ﹤0.01% |
+1,655
| New | +$30.7K |
|
|
AGR
2390
DELISTED
Avangrid, Inc.
AGR
| $31.3K | ﹤0.01% |
680
+371
| +120% | +$15.3K |
|
|
SAGE
2391
DELISTED
Sage Therapeutics
SAGE
| $31.2K | ﹤0.01% |
+1,034
| New | +$34.5K |
|
|
TAHO
2392
DELISTED
Tahoe Resources Inc
TAHO
| $31.1K | ﹤0.01% |
1,770
-1,471
| -45% | -$18.8K |
|
2393
Kforce
KFRC
$1.05B
| $31.1K | ﹤0.01% |
1,839
+1,189
| +183% | +$22.1K |
|
2394
FerroAtlántica
GSM
$818M
| $30.9K | ﹤0.01% |
+3,584
| New | +$32.9K |
|
2395
Precigen
PGEN
$2.24B
| $30.8K | ﹤0.01% |
1,261
+447
| +55% | +$12.7K |
|
2396
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.52B
| $30.6K | ﹤0.01% |
+1,418
| New | +$28.5K |
|
|
WEB
2397
DELISTED
Web.com Group, Inc.
WEB
| $30.4K | ﹤0.01% |
+1,670
| New | +$30.4K |
|
2398
SiriusPoint
SPNT
$2.71B
| $30.1K | ﹤0.01% |
+2,572
| New | +$29.2K |
|
|
CBR
2399
DELISTED
CIBER Inc.
CBR
| $30.1K | ﹤0.01% |
20,058
+8,596
| +75% | +$14.6K |
|
2400
Puma Biotechnology
PBYI
$445M
| $30K | ﹤0.01% |
1,006
+620
| +161% | +$19.4K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2016 Portfolio in Review
As of Q2 2016, BNP Paribas Financial Markets held 3,650 positions worth $22.2B, down 6.2% from $23.6B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
BNP Paribas Financial Markets withdrew a net $1.98B in Q2 2016, closing 87 positions and reducing 780 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $34.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 9.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares Expanded Tech-Software Sector ETF worth $31.6M.
- BNP Paribas Financial Markets's largest Q2 2016 buy was iShares Expanded Tech-Software Sector ETF: 1,500,000 shares worth $31.6M.
- BNP Paribas Financial Markets added most to SPDR Gold Trust in Q2 2016, an estimated $367M increase.
- BNP Paribas Financial Markets's biggest Q2 2016 reduction was Berkshire Hathaway Class B, cutting an estimated $170M.
- BNP Paribas Financial Markets fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $34.9M.
- BNP Paribas Financial Markets's ten largest holdings make up 36% of its $22.2B portfolio in Q2 2016.
- BNP Paribas Financial Markets opened 978 new positions and closed 87 in Q2 2016.
- BNP Paribas Financial Markets's portfolio value fell 6.2% quarter-over-quarter to $22.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2016, filed 6 Jul 2016.